| Product NDC: | 55045-3207 | 
| Proprietary Name: | EpiPen | 
| Non Proprietary Name: | Epinephrine | 
| Active Ingredient(s): | .3 mg/.3mL & nbsp; Epinephrine | 
| Administration Route(s): | INTRAMUSCULAR | 
| Dosage Form(s): | INJECTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 55045-3207 | 
| Labeler Name: | Dispensing Solutions, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA019430 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 19871222 | 
| Package NDC: | 55045-3207-2 | 
| Package Description: | 1 CONTAINER in 1 CARTON (55045-3207-2) > 1 SYRINGE, GLASS in 1 CONTAINER > .3 mL in 1 SYRINGE, GLASS | 
| NDC Code | 55045-3207-2 | 
| Proprietary Name | EpiPen | 
| Package Description | 1 CONTAINER in 1 CARTON (55045-3207-2) > 1 SYRINGE, GLASS in 1 CONTAINER > .3 mL in 1 SYRINGE, GLASS | 
| Product NDC | 55045-3207 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Epinephrine | 
| Dosage Form Name | INJECTION | 
| Route Name | INTRAMUSCULAR | 
| Start Marketing Date | 19871222 | 
| Marketing Category Name | NDA | 
| Labeler Name | Dispensing Solutions, Inc. | 
| Substance Name | EPINEPHRINE | 
| Strength Number | .3 | 
| Strength Unit | mg/.3mL | 
| Pharmaceutical Classes | Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient] |